Hsbc Holdings PLC Guardant Health, Inc. Transaction History

Hsbc Holdings PLC

$176 Billion
Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 5,708 shares of GH stock, worth $538,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,708

Previous 52,042 89.03%

Holding current value

$538,663

Previous $2.71 Million 86.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$40.98 - $67.42 $1.9 Million - $3.12 Million	-46,334 Reduced 89.03%	5,708 $356,000
Q2 2025 Aug 13, 2025	BUY	$37.05 - $52.04 $1.23 Million - $1.73 Million	33,230 Added 176.64%	52,042 $2.71 Million
Q1 2025 May 14, 2025	SELL	$31.77 - $49.94 $6,322 - $9,938	-199 Reduced 1.05%	18,812 $801,000
Q4 2024 Feb 14, 2025	BUY	$20.2 - $38.11 $78,032 - $147,218	3,863 Added 25.5%	19,011 $580,000
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $1.22 Million - $1.98 Million	-54,598 Reduced 78.28%	15,148 $347,000
Q2 2024 Aug 12, 2024	SELL	$16.07 - $31.84 $360,305 - $713,884	-22,421 Reduced 24.33%	69,746 $2.01 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $833,117 - $1.31 Million	48,635 Added 111.72%	92,167 $1.9 Million
Q4 2023 Feb 12, 2024	BUY	$21.58 - $29.5 $565,201 - $772,634	26,191 Added 151.04%	43,532 $1.18 Million
Q3 2023 Nov 13, 2023	SELL	$25.8 - $39.97 $601,372 - $931,660	-23,309 Reduced 57.34%	17,341 $513,000
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $496,822 - $901,825	23,726 Added 140.19%	40,650 $1.46 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $387,898 - $571,354	16,924 New	16,924 $396,000
Q2 2022 Aug 11, 2022	SELL	$28.82 - $77.35 $26,831 - $72,012	-931 Reduced 4.56%	19,485 $786,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $255,483 - $532,094	5,295 Added 35.02%	20,416 $1.35 Million
Q4 2021 Feb 11, 2022	BUY	$88.71 - $120.43 $233,129 - $316,490	2,628 Added 21.04%	15,121 $1.51 Million
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $340,558 - $455,722	-3,448 Reduced 21.63%	12,493 $1.57 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $980,355 - $1.48 Million	8,931 Added 127.4%	15,941 $1.98 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $862,347 - $1.22 Million	-6,788 Reduced 49.2%	7,010 $1.07 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $1.15 Million - $1.56 Million	11,506 Added 502.01%	13,798 $1.78 Million
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $184,093 - $256,245	2,292 New	2,292 $257,000

Others Institutions Holding GH

# of Institutions

450

Shares Held

130M

Call Options Held

2.04M

Put Options Held

2.9M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.65B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Guardant Health, Inc. Transaction History